What had started out as local support transformed into a worldwide movement that is averaging more than three donor matches a month to help save the lives of other mothers, fathers, sons and daughters battling blood cancer.
At the Mavericks we have been diving into any and all advances in medical science that can give us a competitive edge. I'm not talking performance enhancing drugs, I'm talking proactive analysis and advanced recovery methodologies. One that is obvious is the use of stem cells.
Some weeks ago I gave birth to a child after being pregnant for more than four years. The birth was postponed several times, but finally it came; along with 12 brothers and sisters, and with more than 1,000 parents.
Would you let a radiologist do your brain surgery? Would you pick a dermatologist to do your open-heart surgery? So why then do so many patients who get stem cell treatments have such low expectations for the doctors that do their stem cell treatments?
Advanced Cell Technology is seeking the go-ahead from the FDA to initiate the first clinical trials using the iPSC-derived cells later this year. They plan to produce platelets that can be used for blood-clotting diseases. It is time that stem cells gain their place in medicine.
We are in control of our health, and can and should be proactive. Without physician referral, it is imperative that we take upon ourselves the initiative to research and explore these and any natural therapeutic options.
The expanded and rejuvenated immune cells would retain their prior anti-tumor "memory," be primed to fight the tumor and thus significantly augment the ability of the immune system to slow down the tumor growth.
A paper published in Nature suggests that the endogenous regenerative potential of the adult heart is very limited. The low rate of self-renewal in the adult heart sounds like bad news for researchers who thought that the heart had the ability to heal itself after a heart attack.
At this month's symposium organized by the International Society for Stem Cell Research, molecular biologist Rick Young presented some very provocative data that is bound to result in controversial discussions about how researchers should assess gene expression.
One of the more memorable ads this election is the House Majority PAC's attack on Coffman for opposing embryonic stem cell research. In its Truth Test on this topic, 9News should have said more about the ramifications of Coffman's position.
Imagine the possibilities. We could replace cells lost in diseases, from those that produce insulin in the pancreas of patients with type 1 diabetes, to the brain cells destroyed in Parkinson's disease.